Katherine Sinderson Participates in PLI’s “Securities Litigation 2017” Program
April 5, 2017
BLB&G partner Katherine Sinderson was a featured speaker at the Practising Law Institute’s “Securities Litigation 2017: From Investigation to Trial” on April 5, 2017 in New York City.
Ms. Sinderson is involved in a variety of the firm’s practice areas, including securities fraud, corporate governance, and advisory services. She is currently a member of the teams prosecuting securities class actions against Salix Pharmaceuticals, Dole, GNC and SunEdison, as well as litigation arising from the failure of the major mid-Atlantic bank, Wilmington Trust. Most recently, Ms. Sinderson played a key role in two of the largest cases in the firm’s history, both of which settled near trial for billions of dollars on behalf of investors. In In re Merck Securities Litigation, she was a member of the small trial team which resulted in a $1.062 billion settlement. She was also a member of the trial team prosecuting In re Bank of America Securities Litigation, which resulted in a recovery of $2.425 billion, the single largest securities class action recovery ever resolving violations of Sections 14(a) and 10(b) of the Securities Exchange Act and one of the largest shareholder recoveries in history. She was recently recognized as a national “Rising Star” by Law360 for her work in securities litigation. She was also named to Benchmark Litigation’s “Under 40 Hot List,” which recognizes her as one the nation’s most accomplished legal partners under the age of 40
New York City